Atlas Trials

Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer

Clinical trial NCT03617679 · COMPLETED

Trial details

NCT number
NCT03617679
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Endometrial Cancer
Start date
2019-03-06
Primary completion
2023-10-31
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.